Sedation or Anesthesia Before Cervical Cancer Brachytherapy

Volume 2 - Issue 5

Antonio Cassio Assis Pellizzon*

Received: September 21, 2018;   Published: September 27, 2018

DOI: 10.32474/IGWHC.2018.02.000146

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Cervical cancer (CC) is a neoplasm with great potential for prevention, but it is still a public health problem in most developing countries. There are no significant differences between the use of high dose rate (HDR-BT) and low dose rate (LDR-BT) brachytherapy when considering overall, disease specific and recurrence free survivals. Cervical dilatation is mandatory for the insertion of intrauterine tandems in any of the techniques cited above. Pain and discomfort may eventually be limiting factors of the outpatient procedure and may lead to unsatisfactory results in terms of adequate position of the applicator set. We reviewed the current sedation and anesthetic options for comfort and safety procedures when performing HDR-BT.

Abstract| Introduction| Conclusion| References|